These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9669843)

  • 1. Release of clonal block in B cell chronic lymphocytic leukaemia by engagement of co-operative epitopes on CD40.
    Jacob A; Pound JD; Challa A; Gordon J
    Leuk Res; 1998 Apr; 22(4):379-82. PubMed ID: 9669843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.
    Fluckiger AC; Rossi JF; Bussel A; Bryon P; Banchereau J; Defrance T
    Blood; 1992 Dec; 80(12):3173-81. PubMed ID: 1281692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells.
    Furman RR; Asgary Z; Mascarenhas JO; Liou HC; Schattner EJ
    J Immunol; 2000 Feb; 164(4):2200-6. PubMed ID: 10657675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD40 ligation inhibits IL-2 and SAC+IL-2 induced proliferation in chronic lymphocytic leukaemia cells.
    Söderberg O; Christiansen I; Carlsson M; Nilsson K
    Scand J Immunol; 1997 Jun; 45(6):706-14. PubMed ID: 9201312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand.
    Buske C; Gogowski G; Schreiber K; Rave-Fränk M; Hiddemann W; Wörmann B
    Exp Hematol; 1997 Apr; 25(4):329-37. PubMed ID: 9131008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells.
    Porakishvili N; Memon A; Vispute K; Kulikova N; Clark EA; Rai KR; Nathwani A; Damle RN; Chiorazzi N; Lydyard PM
    Br J Haematol; 2011 May; 153(4):486-98. PubMed ID: 21443749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of the CD95 receptor and defect CD40-mediated signal transduction in B-chronic lymphocytic leukemia cells.
    Laytragoon-Lewin N; Duhony E; Bai XF; Mellstedt H
    Eur J Haematol; 1998 Oct; 61(4):266-71. PubMed ID: 9820634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cytoplasmic, surface and soluble forms of CD40 ligand in mouse B cells.
    Wykes M; Poudrier J; Lindstedt R; Gray D
    Eur J Immunol; 1998 Feb; 28(2):548-59. PubMed ID: 9521065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope-dependent synergism and antagonism between CD40 antibodies and soluble CD40 ligand for the regulation of CD23 expression and IgE synthesis in human B cells.
    Challa A; Pound JD; Armitage RJ; Gordon J
    Allergy; 1999 Jun; 54(6):576-83. PubMed ID: 10435471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activation of low-grade non-Hodgkin's lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand.
    Buske C; Twiling A; Gogowski G; Schreiber K; Feuring-Buske M; Wulf GG; Hiddemann W; Wörmann B
    Leukemia; 1997 Nov; 11(11):1862-7. PubMed ID: 9369419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of LFA-1 independent human B cell proliferation and differentiation by binding of CD40 with its ligand.
    Néron S; Pelletier A; Chevrier MC; Monier G; Lemieux R; Darveau A
    Immunol Invest; 1996; 25(1-2):79-89. PubMed ID: 8675236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal cross-linking and epitope requirements for CD40-dependent suppression of apoptosis contrast with those for promotion of the cell cycle and homotypic adhesions in human B cells.
    Pound JD; Challa A; Holder MJ; Armitage RJ; Dower SK; Fanslow WC; Kikutani H; Paulie S; Gregory CD; Gordon J
    Int Immunol; 1999 Jan; 11(1):11-20. PubMed ID: 10050669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of T cell/B cell interaction by B-CLL cells.
    Kneitz C; Goller M; Wilhelm M; Mehringer C; Wohlleben G; Schimpl A; Tony HP
    Leukemia; 1999 Jan; 13(1):98-104. PubMed ID: 10049067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40 activation: potential for specific immunotherapy in B-CLL.
    von Bergwelt-Baildon M; Maecker B; Schultze J; Gribben JG
    Ann Oncol; 2004 Jun; 15(6):853-7. PubMed ID: 15151939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies.
    Wang D; Freeman GJ; Levine H; Ritz J; Robertson MJ
    Br J Haematol; 1997 May; 97(2):409-17. PubMed ID: 9163608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
    de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
    Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-alpha stimulates proliferation and cytokine secretion of CD40-stimulated B cell chronic lymphocytic leukemia cells in vitro.
    Brass U; Tretter T; Schneller F; Schuler M; Huber C; Peschel C
    J Interferon Cytokine Res; 1999 Apr; 19(4):335-43. PubMed ID: 10334384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches.
    Hayden RE; Pratt G; Roberts C; Drayson MT; Bunce CM
    Leuk Lymphoma; 2012 Apr; 53(4):537-49. PubMed ID: 21812539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40 cross-linking inhibits specific antibody production by human B cells.
    Callard RE; Herbert J; Smith SH; Armitage RJ; Costelloe KE
    Int Immunol; 1995 Nov; 7(11):1809-15. PubMed ID: 8580079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions.
    Oxenius A; Campbell KA; Maliszewski CR; Kishimoto T; Kikutani H; Hengartner H; Zinkernagel RM; Bachmann MF
    J Exp Med; 1996 May; 183(5):2209-18. PubMed ID: 8642330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.